Browsing Tag
npj Digital Medicine
2 posts
Tempus (Nasdaq: TEM) gains real-world NHS evidence for Paige Prostate AI, but scale-up still depends on economics
Prospective NHS deployment strengthens the clinical case for Tempus AI’s digital pathology portfolio, although cost effectiveness, infrastructure readiness and commercial conversion remain unproven.
ScreenPoint Medical bets on risk prediction and workflow AI after $16m funding boost
ScreenPoint Medical has raised $16 million to expand its breast imaging AI platform. Read why this funding could reshape screening and risk prediction.